Expectations trend
FY2028 · fiscal year ending 2028-05-31 · fmp
AXIL Brands Inc (AXIL)
AMEXInformation TechnologyHousehold & Personal ProductsSnapshot 2026-11-05
$5.19-7.32%
Close 2026-11-05 · 1-day change
AMEXInformation TechnologyHousehold & Personal ProductsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.93 → 0.75 EPS · FY ending May 31, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AXIL yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS remains positive at $0.04 per share next quarter | Earnings per share are positive and stable at $0.04 next quarter. | Intact | EPS falls below $0.02 next quarter | Diluted EPS: $0.05 per share FY2027-Q1; GAAP. Published target: EPS >= $0.04. The stored target says 2026-Q4; this source reports FY2027-Q1. Fiscal/calendar alignment needs review. Oct 6, 20260.05 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-05-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
AXIL is a small-cap growth business with product-launch and distribution execution risk, rather than a proven steady compounder. Its long-term thesis is in a watch state: management’s priorities are consistent, but recent financial delivery has weakened.
The valuation is described as cheap versus peers, with a negative expectations gap, meaning the model sees expectations below its view of the business. The evidence also says pricing is justified and fragility is low, so the valuation signal alone does not remove the execution concerns.
Near term, results may remain uneven: revenue and operating income fell in the latest quarter, after an earlier quarter with higher revenue, and AXIL has missed in recent periods. Management has expanded retail distribution and reported more than $3.6 million in XCOR II orders through September, but conversion of those orders into revenue and broader gains from product investment remain unproven.
The key company-specific test is whether XCOR II orders turn into revenue and whether wider retail distribution supports a recovery in financial delivery. A guidance cut on the next call would be a meaningful negative; easing interest rates or stabilization among major technology companies could support the sector backdrop, but would not resolve AXIL’s execution risks.
Over the next 1 to 3 years, the long-term thesis depends on AXIL turning its retail footprint and new-product traction into more consistent results. Recent misses, high risk, and weaker latest-quarter performance make execution the central issue. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in AXIL Brands Inc's published investment case. The stated target is 67% to 71% gross margin. |
| Intact |
| Gross margin falls below 67% next quarter |
Gross margin: 82.62% FY2027-Q1; GAAP. Published target: 67% to 71% gross margin. The stored target says 2026-Q4; this source reports FY2027-Q1. Fiscal/calendar alignment needs review. Oct 6, 202682.617612 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows at least 21% annually driven by retail expansion | AXIL grows revenue about 21% yearly, driven by retail channel expansion. | Intact | YoY revenue growth falls below 15% next year | Revenue: $6.09M FY2027-Q1; GAAP. Published target: >=21% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Oct 6, 20266,090,383 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.93 → $0.75 · observed estimates
$0.05B → $0.04B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-29 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-08-30 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-08-31 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-01 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-02 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-03 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-04 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-05 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-06 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-07 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-08 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-09 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-10 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-11 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-12 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-13 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-14 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-15 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-16 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-17 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-18 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-19 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-20 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-21 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-22 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-23 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-24 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-25 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-26 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-27 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-28 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-29 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-09-30 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-01 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-02 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-03 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-04 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-05 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-06 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-07 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-08 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-09 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-10 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-11 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-12 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-13 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-14 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-15 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-16 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-17 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-18 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-19 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-20 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-21 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-22 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-23 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-24 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-25 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-26 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-27 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-28 | $0.93 | $46,040,896 | 1 / 1 |
| 2026-10-29 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-10-30 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-10-31 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-11-01 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-11-02 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-11-03 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-11-04 | $0.75 | $41,881,765 | 1 / 1 |
| 2026-11-05 | $0.75 | $41,881,765 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.